National Bank of Canada’s VolitionRx Ltd VNRX Stock Holding History

National Bank of Canada’s Portfolio VNRX Stock Details VNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-50	Closed	-$741	–	2907
2023 Q3	$741	Hold	50	–	–	﹤0.01%	2619
2023 Q2	$1.39K	Hold	50	–	–	﹤0.01%	2516
2023 Q1	$1.91K	Hold	50	–	–	﹤0.01%	2443
2022 Q4	$2.4K	Hold	50	–	–	﹤0.01%	2462
2022 Q3	$1K	Hold	50	–	–	﹤0.01%	2642
2022 Q2	$2K	Hold	50	–	–	﹤0.01%	2630
2022 Q1	$3K	Hold	50	–	–	﹤0.01%	2674
2021 Q4	$3K	Buy	+50	New	+$3.41K	﹤0.01%	2649

Other funds holding VNRX

LIM

Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SAMC

Spectrum Asset Management (California) Newport Beach, California $360M AUM 19.03% 1-Year Est. Return

National Bank of Canada's VNRX Position: Q4 2023 in Review

National Bank of Canada sold out of VolitionRx Ltd (VNRX) in Q4 2023, closing a stake of 50 shares — an estimated $741 sold.

National Bank of Canada first reported a position in VNRX in Q4 2021 and held it in 8 quarters. The position peaked at $3K in Q1 2022. 28 funds tracked by Wall St. Rank hold VNRX as of Q4 2023.

National Bank of Canada reported no remaining VolitionRx Ltd position as of Q4 2023 after selling out during the quarter.
National Bank of Canada sold 50 VolitionRx Ltd shares in Q4 2023, an estimated $741.
National Bank of Canada first reported a position in VolitionRx Ltd in Q4 2021 and held it in 8 quarters.
National Bank of Canada's VolitionRx Ltd position peaked at $3K in Q1 2022.
28 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2023.

Based on National Bank of Canada's 13F filing for Q4 2023, filed 6 Feb 2024.